ArticleThe Biochemical journal2025
Mechanistic insights into DNA binding by BD1 of the TAF1 tandem bromodomain module.
Article in The Biochemical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structural Genomics Defines PBRM1 Bromodomain Variant Function in ccRCC.Human mutation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Transcription initiation factor TFIID subunit 1 (TAF1) is a pivotal component of the TFIID complex, critical for RNA polymerase II-mediated transcription initiation. However, the molecular basis by which TAF1 recognizes and associates with chromatin remains incompletely understood. Here, we report that the tandem bromodomain module of TAF1 engages nucleosomal DNA through a distinct positively charged surface patch on the first bromodomain (BD1). Electrostatic potential mapping and molecular docking revealed a prominent basic region on BD1 that facilitates interaction with DNA, predominantly driven by hydrogen bonds and electrostatic forces, as supported by molecular dynamics simulations. Site-directed mutagenesis identified three key positively charged residues (R1435, K1436, and R1437) within the αA helix of BD1, constituting an 'RKR' basic patch essential for DNA binding. Electrophoretic mobility shift assays demonstrated that the TAF1 tandem bromodomain binds DNA in a concentration-dependent manner with moderate preference for AT-rich sequences, attributed to this RKR motif. Importantly, DNA binding occurs independently of histone acetyllysine recognition by the bromodomains, as acetylated histone H4 peptides or mutations in the acetyllysine-binding pocket did not affect DNA interaction. Furthermore, nucleosome pulldown assays revealed that disruption of the BD1 RKR patch significantly reduces binding to acetylated nucleosomes, highlighting its role in facilitating chromatin engagement. Collectively, our findings establish the RKR basic patch on TAF1 BD1 as a critical determinant for DNA interaction, providing mechanistic insight into how TAF1 tandem bromodomains co-ordinate dual recognition of nucleosomal DNA and histone acetylation. These results offer a molecular basis for understanding how TAF1 may contribute to transcriptional regulation via chromatin engagement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.